BRKR

Bruker Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth 1/10
  • Value 3/10
Bruker sales and earnings growth
BRKR Growth
Low
  • Revenue Y/Y 2.08%
  • EPS Y/Y -119.74%
  • FCF Y/Y -68.16%
Bruker gross and profit margin trends
BRKR Profitability
Neutral
  • Gross margin 45.90%
  • EPS margin -0.70%
  • ROIC 5Y 11.14%
Bruker recent dividend growth
BRKR Dividends
  • Dividend yield 0.59%
  • Growth 3Y 0.00%
  • Payout ratio -133%
Bruker net debt vs free cash flow
BRKR Risk
Great
  • Debt / Equity 0.8
  • Debt / FCF 39.5
  • Interest coverage 1.5

Bruker stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗